242723 ⎘
FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
#2Formulations and methods for lyophilization and lyophilates provided thereby
#3Formulations and methods for lyophilization and lyophilates provided thereby
#4CALCIUM CARBONATE GRANULATION
#5Oral Drug Delivery System
#6SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING BENZOFURAN DERIVATIVES
#7Calcium carbonate granulation
#8Oral drug delivery system
#9Oral drug delivery system
#10Calcium carbonate granulation
#11Formulations and methods for lyophilization and lyophilates provided thereby
#12Oral drug delivery system
#13Oral drug delivery system
#14Oral drug delivery system
#15Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
#16Formulations and methods for lyophilization and lyophilates provided thereby
#17Formulations for cathepsin K inhibitors
#18Utilization of dialkylfumarates
#19Calcium carbonate granulation
#20Calcium carbonate granulation
#21Calcium carbonate granulation
#22Calcium carbonate granulation
#23Calcium carbonate granulation
#24Calcium carbonate granulation
#25Calcium carbonate granulation
#26Calcium carbonate granulation
#27Calcium carbonate granulation
#28Calcium carbonate granulation
#29Calcium carbonate granulation
#30Calcium carbonate granulation
#31Oral drug delivery system
#32Oral drug delivery system
#33ANTIDEPRESSANT DOSAGE FORM
#34Lipid supplements for maintaining health and treatment of acute and chronic disorders
#35Utilization of dialkylfumarates
#36IBUPROFEN AND NARCOTIC ANALGESIC COMPOSITIONS
#37Calcium Carbonate Granulation
#38FORMULATIONS FOR CATHEPSIN K INHIBITORS
#39Formulations and methods for lyophilization and lyophilates provided thereby
#40ANTIDEPRESSANT DOSAGE FORM
#41Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
#42Oral compositions containing a salivation inducing agent
#43Utilization of dialkylfumarates
#44Utilization of dialkylfumarates
#45Oral drug delivery system
#46Oral drug delivery system
#47Treating allergic and inflammatory conditions
#48Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#49Oral drug delivery system
#50STABILIZED LANTHANUM CARBONATE COMPOSITIONS
#51Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation
#52Solid pharmaceutical compositions containing benzofuran derivatives
#53Composition and use
#54Tablet composition with a prolonged release of tamsulosin
#55Calcium compositions
#56Utilization of dialkylfumarates
#57Utilization of dialkylfumarates
#58Sustained-release preparations of quinolone antibiotics
#59INDIUM SUPPLEMENT COMPOSITIONS AND METHODS THEREFOR
#60Calcium carbonate granulation
#61Calcium carbonate granulation
#62BETA-LACTAM ANTIBIOTIC-CONTAINING TABLET AND PRODUCTION THEREOF
#63Pharmaceutical compositions comprising meloxicam and methods of their preparation
#64Oral compositions containing a salivation inducing agent
#65Film coated tablet for improved upper gastrointestinal tract safety
#66Method of preparing sustained-release preparations of quinolone antibiotics
#67Calcium carbonate granulation
#68Calcium carbonate granulation
#69Calcium carbonate granulation
#70Antidepressant dosage form
#71Fast-dissolving pharmaceutical composition
#72Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
#73Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof
#74Fast disintegrating tablet
#75Sublingual Formulations of Ketorolac or Salts Thereof
#76Stabilized lanthanum carbonate compositions
#77Antidepressant dosage form
#78Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
#79Directly compressible tricalcium phosphate
#80Amino acid modulated extended release dosage form
#81Indium supplement compositions and methods therefor
#82Ibuprofen and narcotic analgesic compositions
#83Calcium carbonate granulation
#84Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#85Gastric retention dosage form having multiple layers